Connect with us

Health

Health News from Gavi Featured on ET HealthWorld

Published

on

Gavi, Health News, ET HealthWorld

In a proactive effort to increase access to the human papillomavirus (HPV) vaccine for adolescent girls worldwide, the Vaccine Alliance and manufacturers have ramped up production. According to a new insight paper by Gavi, the Vaccine Alliance, the supply of HPV vaccines is projected to increase, with the goal of meeting demand by 2025.

The Gavi market-shaping roadmap for HPV vaccines emphasizes the need for careful planning in 2024 to ensure a sustainable pipeline of supply. Collaborative efforts between partners, manufacturers, and countries are essential to reach the target of protecting 86 million girls by 2025. The Chief Programme Officer of Gavi, Aurélia Nguyen, stressed the importance of managing current doses, securing donor and manufacturer support, and expanding access to reach more girls.

Despite historical supply challenges and barriers exacerbated by the COVID-19 pandemic, Gavi has been working diligently to protect adolescent girls with the HPV vaccine. The coverage in 2022 has surpassed pre-pandemic levels at 21%, but there is still a gap in ideal coverage, especially in lower-income countries where most unprotected girls are located.

Cervical cancer continues to be a significant health concern, with 348,000 deaths reported in 2022, 90% of which occurred in low- and middle-income countries. The HPV vaccine, which is 90% effective in preventing the disease, plays a crucial role in reducing these fatalities. With an increased number of suppliers and vaccines, establishing a secure and sustainable supply chain is imperative to ensure universal access to the vaccine and protect adolescent girls globally.

Through strategic market objectives and targeted resources, Gavi aims to reach 86 million adolescent girls by 2025 and prevent 1.4 million deaths. The revitalized HPV vaccine program in countries like Nigeria, Bangladesh, and Indonesia has already reached over eight million girls, showcasing progress towards the goal of widespread protection against HPV.

Click to comment

You must be logged in to post a comment Login

Leave a Reply

Trending